Optibrium_logo_1380 v2.png

Optibrium

Drug Discovery

Membership category
Emerging Y1

F10-13 Blenheim House, Cambridge Innovation Park, Denny End Road, Cambridge, CB25 9GL, United Kingdom

Optibrium at a glance

Optibrium delivers exceptional software and AI solutions to support drug discovery, all backed up by rigorous peer-reviewed research.

About Optibrium

Optibrium develops exceptional software and AI solutions that help scientists advance their discovery projects. Cutting-edge science, backed up by rigorous research, underpins their intuitive software for compound design, optimisation and data analysis. Optibrium’s comprehensive in silico platform improves the speed, efficiency, and productivity of the discovery process and supports a worldwide customer base, including leading pharma, biotech, agrochemical and flavouring companies and not-for-profit and academic groups. Optibrium was founded in 2009 and is headquartered in Cambridge, UK, with a US subsidiary, Optibrium Inc., based in Cambridge MA.

Therapeutic area(s)

Articles Optibrium has contributed to